Catalyst Wire Dossier Catalyst Wire Dossier

Renin-angiotensin system blockers

RAS blocker
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Renin-angiotensin system blockers, covering 2016-09-05 to 2016-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria [Phase 4]

See pricing